Kenvue

Yahoo Finance • last month

Target Stock Needs a Spark. An Activist Investor Could Provide It.

A report that Toms Capital has taken a stake comes as the retailer faces sluggish sales and market-share losses. Continue Reading... Full story

Yahoo Finance • 2 months ago

Pressure grows on Target as activist investor builds stake

US retail chain Target is facing pressure from an activist investor after a sales slump that has wiped out nearly a third of its share PREMIUM Upgrade to read this Financial Times article and get so much more. A Silver or Gold subscript... Full story

Yahoo Finance • 2 months ago

Beauty spending shows pockets of strength as wellness categories decline -- Canaccord Genuity

[Professional make-up artist flat lay on beige background for fashion woman.] Amax Photo/iStock via Getty Images Spending on health and beauty merchandise has been mixed so far this holiday season with trends indicating consumers are wait... Full story

Yahoo Finance • 2 months ago

Here’s What Impacted Kenvue’s (KVUE) in Q3

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the quarter, the market is more focused on the tailwind of policy... Full story

Yahoo Finance • 2 months ago

J&J Hit With $1.5 Billion Talc Verdict

This article first appeared on GuruFocus. Johnson & Johnson (NYSE:JNJ) announced it will appeal after a Baltimore jury gave a shocking judgment of more than $1.5 billion in a dispute over talc and cancer. This keeps a long-running legal s... Full story

Yahoo Finance • 2 months ago

Johnson & Johnson Ordered to Pay $1.56 Billion in Maryland Talc Verdict

This article first appeared on GuruFocus. Johnson & Johnson (NYSE:JNJ) faces a renewed legal and financial overhang after a Maryland state-court jury ordered the company to pay about $1.56 billion to a woman who alleged its talc-based bab... Full story

Yahoo Finance • 2 months ago

J&J Faces Record $1.5 Billion Talc Cancer Verdict

This article first appeared on GuruFocus. Johnson & Johnson (JNJ, Financials) said it will appeal after a jury in Baltimore ordered the firm and its subsidiaries to pay a woman more than $1.5 billion because she believed she got cancer fr... Full story

Yahoo Finance • 2 months ago

Johnson & Johnson pledges appeal following record $1.5 billion U.S. jury verdict in talc cancer case

[Johnson & Johnson offices in Silicon Valley] Sundry Photography/iStock Editorial via Getty Images A Baltimore jury ruled that Johnson & Johnson (JNJ [https://seekingalpha.com/symbol/JNJ]) and its subsidiaries must pay more than $1.5 bill... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC Encourages AVDL, CMA, KVUE Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

INVE$TOR ALERT: The M&A Class Action Firm Encourages KVUE, FSUN, FFWM, and GIFI Shareholders to Protect their Rights

NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC Encourages FFWM, GIFI, FSUN, KVUE Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

Guggenheim Highlights Growth Potential in Johnson & Johnson (JNJ), Maintains Buy

Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Stocks to Buy for the Long Term.Guggenheim Highlights Growth Potential in Johnson & Johnson (JNJ), Maintains Buy On December 5, Guggenheim boosted the firm’s price target on Johns... Full story

Yahoo Finance • 2 months ago

The 5 Best S&P 500 Dividend Aristocrat Stocks to Buy Before 2026

Panchenko Vladimir / Shutterstock.com Investors love S&P 500 dividend stocks, especially those with dependable, high yields, because they provide a substantial passive income stream and offer significant total return potential. Total retu... Full story

Yahoo Finance • 2 months ago

BNP Paribas Exane Lowers Outlook on Kimberly-Clark (KMB) Ahead of 2026 Acquisition

Kimberly-Clark Corporation (NASDAQ:KMB) is included among the 15 Blue Chip Dividend Stocks to Build a Passive Income Porfolio.BNP Paribas Exane Lowers Outlook on Kimberly-Clark (KMB) Ahead of 2026 Acquisition On December 1, Kimberly-Clark... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC Encourages GDOT, KVUE, RPTX, KMB Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

Kenvue Inc. (KVUE): A Bull Case Theory

We came across a bullish thesis on Kenvue Inc. on The Value Road’s Substack. In this article, we will summarize the bulls’ thesis on KVUE which was published before KVUE's acquisition announcement. Kenvue Inc.'s share was trading at $17.35... Full story

Yahoo Finance • 2 months ago

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—RPTX, CNBN, KMB, and KVUE

NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story

Yahoo Finance • 2 months ago

Analysts Note Stronger Outlook as Kimberly-Clark (KMB) Deepens Its Consumer Health Footprint

Kimberly-Clark Corporation (NASDAQ:KMB) is included among the 15 Best Boring Dividend Stocks to Buy.Analysts Note Stronger Outlook as Kimberly-Clark (KMB) Deepens Its Consumer Health Footprint On⁠ November 13, Argus analy⁠st John St‌aszak... Full story

Yahoo Finance • 3 months ago

KVUE Factor-Based Stock Analysis - Martin Zweig

Below is Validea's guru fundamental report for KENVUE INC (KVUE). Of the 22 guru strategies we follow, KVUE rates highest using our Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stoc... Full story

Yahoo Finance • 3 months ago

Kimberly-Clark gains as Morgan Stanley moves to restricted rating

[Kleenex tissues] NoDerog/iStock Unreleased via Getty Images Kimberly-Clark (KMB [https://seekingalpha.com/symbol/KMB]) rose 2.3% as Morgan Stanley moved to a restricted rating on the consumer products company. Morgan Stanley moved to a... Full story